Palvella Therapeutics Inc (PVLA)

EBITDA Margin

-857.81%

TTM · Period ending:

PVLA logo

PVLA EBITDA Margin

Latest reported-857.81%
PVLA TTM EBITDA Margin (-52.58% → -857.81%)
High-resolution chart · PNG

PVLA ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Palvella Therapeutics Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-857.8137%
-93.3907%
-28.446%
-52.5765%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.